Gene · 3915
Papers1,504
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,504
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant. | Invest Ophthalmol Vis Sci | 2023 | 36877514 | PubTator, text mining | PubMed |
| A novel strategy for precise prognosis management and treatment option in colon adenocarcinoma with TP53 mutations. | Front Surg | 2023 | 36843983 | PubTator, text mining | PubMed |
| Dermal PapillaCell-Derived Exosomes Regulate Hair Follicle Stem Cell Proliferation via LEF1. | Int J Mol Sci | 2023 | 36835374 | PubTator, text mining | PubMed |
| First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry. | Int J Mol Sci | 2023 | 36835058 | PubTator, text mining | PubMed |
| Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy. | Int J Mol Sci | 2023 | 36834660 | PubTator, text mining | PubMed |
| Screening and identification of susceptibility genes for osteosarcoma based on bioinformatics analysis. | Ann Transl Med | 2023 | 36819543 | PubTator, text mining | PubMed |
| Big data in corneal diseases and cataract: Current applications and future directions. | Front Big Data | 2023 | 36818823 | PubTator, text mining | PubMed |
| Downregulation of miR-193a/b-3p during HPV-induced cervical carcinogenesis contributes to anchorage-independent growth through PI3K-AKT pathway regulators. | J Med Virol | 2023 | 36799263 | PubTator, text mining | PubMed |
| Circ_0124208 Promotes the Progression of Hepatocellular Carcinoma by Regulating the miR-338-3p/LAMC1 Axis. | Mol Biotechnol | 2023 | 36780058 | PubTator, text mining | PubMed |
| DNA methylation changes and increased mRNA expression of coagulation proteins, factor V and thrombomodulin in Fuchs endothelial corneal dystrophy. | Cell Mol Life Sci | 2023 | 36773096 | PubTator, text mining | PubMed |
| The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism. | Int J Mol Sci | 2023 | 36768977 | PubTator, text mining | PubMed |
| Macrophage Phenotyping in Atherosclerosis by Proteomics. | Int J Mol Sci | 2023 | 36768933 | PubTator, text mining | PubMed |
| Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy. | Int J Mol Sci | 2023 | 36768385 | PubTator, text mining | PubMed |
| Automatic Text-Mining Approach to Identify Molecular Target Candidates Associated with Metabolic Processes for Myotonic Dystrophy Type 1. | Int J Environ Res Public Health | 2023 | 36767649 | PubTator, text mining | PubMed |
| Derivation of the Immortalized Cell Line UM51-PrePodo-hTERT and Its Responsiveness to Angiotensin II and Activation of the RAAS Pathway. | Cells | 2023 | 36766685 | PubTator, text mining | PubMed |
| Investigation on acquired palbociclib resistance by LC-MS based multi-omics analysis. | Front Mol Biosci | 2023 | 36743215 | PubTator, text mining | PubMed |
| GPS2-mediated regulation of the adipocyte secretome modulates adipose tissue remodeling at the onset of diet-induced obesity. | Mol Metab | 2023 | 36731652 | PubTator, text mining | PubMed |
| Statement of Retraction: miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1. | Cell Cycle | 2023 | 36728745 | PubTator, text mining | PubMed |
| Immune response elicited in the tumor microenvironment upon rMV-SLAMblind cancer virotherapy. | Cancer Sci | 2023 | 36715555 | PubTator, text mining | PubMed |
| NID1-related autosomal dominant Dandy-Walker malformation with occipital cephalocele in three generations. | Eur J Med Genet | 2023 | 36702440 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3915/papers?page=11